Argatroban in patients with acute ischemic stroke with early neurological deterioration: a cost-effectiveness analysis from the perspective of Chinese healthcare system

Argatroban in patients with acute ischemic stroke with early neurological deterioration: a cost-effectiveness analysis from the perspective of Chinese healthcare system

Background and ObjectiveStudies have shown that argatroban improves 90-day functional outcomes in patients with acute ischemic stroke (AIS) with early neurological deterioration (END). However, its cost-effectiveness in this patient population remains unclear.MethodsA combination of a short-term dec...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu Xie, Liping Hu, Ping Xu, Xianbin Guo, Junxiu Cai, Min Pan, Jie Tang, Qingtao Gong, Rong Su, Yake Lou, Yan Liu, Li Wang, Ying Yu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Pharmacology
Subjects:
argatroban
sroke
cost effectiveness
early neurological deterioration
ease
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1470373/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2025.1470373/full

Similar Items